1. Home
  2. ASMB vs GENC Comparison

ASMB vs GENC Comparison

Compare ASMB & GENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • GENC
  • Stock Information
  • Founded
  • ASMB 2005
  • GENC 1894
  • Country
  • ASMB United States
  • GENC United States
  • Employees
  • ASMB N/A
  • GENC N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • GENC Construction/Ag Equipment/Trucks
  • Sector
  • ASMB Health Care
  • GENC Industrials
  • Exchange
  • ASMB Nasdaq
  • GENC Nasdaq
  • Market Cap
  • ASMB 225.9M
  • GENC 205.4M
  • IPO Year
  • ASMB 2010
  • GENC N/A
  • Fundamental
  • Price
  • ASMB $37.28
  • GENC $13.58
  • Analyst Decision
  • ASMB Strong Buy
  • GENC
  • Analyst Count
  • ASMB 6
  • GENC 0
  • Target Price
  • ASMB $43.40
  • GENC N/A
  • AVG Volume (30 Days)
  • ASMB 133.7K
  • GENC 20.2K
  • Earning Date
  • ASMB 11-10-2025
  • GENC 08-08-2025
  • Dividend Yield
  • ASMB N/A
  • GENC N/A
  • EPS Growth
  • ASMB N/A
  • GENC N/A
  • EPS
  • ASMB N/A
  • GENC 1.03
  • Revenue
  • ASMB $37,191,000.00
  • GENC $117,527,000.00
  • Revenue This Year
  • ASMB $14.29
  • GENC N/A
  • Revenue Next Year
  • ASMB N/A
  • GENC N/A
  • P/E Ratio
  • ASMB N/A
  • GENC $12.50
  • Revenue Growth
  • ASMB 31.30
  • GENC 3.90
  • 52 Week Low
  • ASMB $7.75
  • GENC $10.80
  • 52 Week High
  • ASMB $39.71
  • GENC $22.49
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 66.12
  • GENC 50.46
  • Support Level
  • ASMB $35.50
  • GENC $12.22
  • Resistance Level
  • ASMB $39.65
  • GENC $13.83
  • Average True Range (ATR)
  • ASMB 2.14
  • GENC 0.50
  • MACD
  • ASMB 0.05
  • GENC 0.01
  • Stochastic Oscillator
  • ASMB 72.27
  • GENC 69.34

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About GENC Gencor Industries Inc.

Gencor Industries Inc and its subsidiaries is a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company has one reporting segment, equipment for the highway construction industry. The firm's principal products include asphalt plants, combustion systems, hot mix asphalt plants, fluid heat transfer systems, and asphalt pavers.

Share on Social Networks: